BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//The European School of Multimodality Imaging & Therapy (ESMIT) - ECPv6.15.11//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:The European School of Multimodality Imaging & Therapy (ESMIT)
X-ORIGINAL-URL:https://esmit.eanm.org
X-WR-CALDESC:Events for The European School of Multimodality Imaging & Therapy (ESMIT)
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Vienna
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20270328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20271031T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20280326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20281029T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20250301T080000
DTEND;TZID=Europe/Vienna:20270330T170000
DTSTAMP:20260421T235517
CREATED:20251117T100100Z
LAST-MODIFIED:20251117T102105Z
UID:3297-1740816000-1806426000@esmit.eanm.org
SUMMARY:Fundamentals of Research in Imaging and Theranostics Part 2
DESCRIPTION:UEMS EACCME has granted the accreditation of 4.5 CME credits for this event. \n\n\n\n \n\n\n\n \n\n\n\nThis online course is part of a longer line of research methodology which is aimed at providing interested participants with information about the preclinical development and clinical translation\, as well as the design\, conductance and reporting of clinical research trials\, with a specific emphasis on radiopharmaceuticals for both diagnostic and therapeutic applications. \n\n\n\n \n\n\n\n\n\n\n\n \n\n\n\nSave yourself a seatEnter the eLearning store to register for the course. Having trouble? See the short tutorial here. Register now!\n\n\n\n \n\n\n\n\n\n\n\n \n\n\n\n \n\n\n\n \n\n\n\nLearning Objectives\n\n\n\n \n\n\n\n \n\n\n\nFor phase I/II clinical studies with radiopharmaceuticals to understand:    \n\n\n\n\nThe principles of technical realisation of the study including assessment of safety of investigational medicinal product \n\n\n\nThe statistical considerations\, including the estimation of number of subjects to be enrolled  \n\n\n\nThe regulatory requirements for performing clinical studies with radiopharmaceutical with special focus on diagnostic radiopharmaceuticals and to summarise the particularities of these studies \n\n\n\nThe ethical and medical considerations in common and vulnerable populations \n\n\n\nThe principles of preparing the clinical study protocol  \n\n\n\nThe objectives\, endpoints and outcome measures  \n\n\n\nThe principles of patient selection\, inclusion and non-inclusion criteria \n\n\n\nThe principles of establishment of the standard of truth\, the role of the comparator\, superiority/non-inferiority/equivalence(?) studies) & practical examples\n\n\n\n\n \n\n\n\n \n\n\n\nTarget Audience\n\n\n\n \n\n\n\n \n\n\n\n\nPersonnel involved in designing and/or performing phase I/II clinical research with diagnostic radiopharmaceuticals (e.g. nuclear medicine physicians\, pharmacists\, physicists\, nurses\, technologist\, administrative staff). \n\n\n\nPersonnel involved in assessment of the ethical\, medical and methodologic aspects of phase I/II research protocols with diagnostic radiopharmaceuticals. \n\n\n\nAll professionals interested in phase I/II clinical research with diagnostic radiopharmaceuticals \n\n\n\n\n \n\n\n\n \n\n\n\n \n\n\n\nFaculty\n\n\n\n \n\n\n\n \n\n\n\n\n\nChiara GranaSpeaker \n\n\n\n\n\nBart de KeizerSpeaker \n\n\n\n\n\nCaroline StokkeSpeaker \n\n\n\n\n\nJean-Noel TalbotSpeaker \n\n\n\n\n\n\n\nLuisa Roldao PereiraSpeaker \n\n\n\n\n\nJohn Andrei IagaruSpeaker \n\n\n\n\n\nSona BalogovaSpeaker
URL:https://esmit.eanm.org/event/fundamentals-of-research-part-2/
CATEGORIES:Online Course,Research Methods,Self-paced Online Course,Theranostics
ORGANIZER;CN="ESMIT":MAILTO:esmit@eanm.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20250320T090000
DTEND;TZID=Europe/Vienna:20250321T160000
DTSTAMP:20260421T235517
CREATED:20241017T082921Z
LAST-MODIFIED:20250314T130204Z
UID:1951-1742461200-1742572800@esmit.eanm.org
SUMMARY:Cardiac Amyloidosis Imaging: History\, Status Quo and Outlook
DESCRIPTION:This course provides a comprehensive overview of the multimodality diagnosis of cardiac amyloidosis. Background information on amyloidosis in general is presented and typical disease manifestations are discussed. Furthermore\, the significance of cardiac amyloidosis will be discussed in detail and possible therapeutic options will be explained. Imaging modalities will include a focus on echocardiography\, cardiac MRI\, SPECT\, and PET\, with discussion of the various tracers available. It will be elaborated when which of the different imaging modalities can be used appropriately and multimodality concepts will also be discussed. The course content will be developed using numerous case examples. Furthermore\, the course participants should solve cases independently and discuss them with the other course participants. \n\n\n\n\n\n\n\nRegister nowRegistrations are closed. Please contact us at esmit@eanm.org if you are still interested in signing up for the course. \n\n\n\n\n\n\n\n\nLearning Objectives\n\n\n\n\nGain a deep insight into the disease of amyloidosis and in particular the cardiac involvement of amyloidosis.\n\n\n\nGain a deep insight into the disease of amyloidosis and in particular the cardiac involvement of amyloidosis.\n\n\n\nBecome familiar with the various imaging modalities available for the diagnosis of cardiac amyloidosis.\n\n\n\nTo learn the appropriate use of diagnostic options in cardiac amyloidosis (keyword: diagnostic algorithm).\n\n\n\nTo independently make the correct diagnosis of cardiac amyloidosis on the basis of case studies.\n\n\n\nTo learn the possibilities of quantification of SPECT and PET.\n\n\n\n\n\n\nTarget Audience\n\n\n\n\nNuclear physicians\, cardiologists\, internists and radiologists who are interested in amyloidosis and want to deepen their knowledge of cardiac amyloidosis diagnostics.\n\n\n\n\n\n\n\n\n\nProgrammeView the Programme\n\n\n\n\n\n\n\nFaculty\n\n\n\n\n\nStephan NekollaSpeakerMunich\, Germany \n\n\n\n\n\nRaffaella CalabrettaSpeakerVienna\, Austria \n\n\n\n\n\nCarmela NappiSpeakerNaples\,Italy \n\n\n\n\n\nDietrich BeitzkeSpeakerVienna\,Austria \n\n\n\n\nMichael PoledniczekSpeakerVienna\,Austria \n\n\n\n\nRegistration Details\n\n\n\nRegistration FeeMode of PaymentCancellation Policy\n\nCourse Fee               € 950.- \n\n\n\nRegistration Fee includes: \n\n\n\n\nElectronic Course Book\, including all Slides\n\n\n\nCoffee & Lunch Breaks\n\n\n\n\nRegistration Fee does NOT include: \n\n\n\n\nTravel to the Venue\n\n\n\nAccommodation\n\n\n\n\n\n\nRegistration fees need to be paid 1 week prior to the event. In case the payment is not received by this deadline\, the registration needs to be cancelled. Payment can be settled by Credit Card Cheques will not be accepted \n\n\n\n\n\nCancellations must be notified in writing to the EANM Office. Telephone cancellations cannot be accepted. Substitutions will be accepted if the name and e-mail address of the substitute are sent to the EANM Office 4 weeks prior to the event. In the case of cancellation 4 weeks before the course\, we will refund you the fee less a € 100\,- administration charge. After this date\, we cannot grant any refund for cancellations. Any refund will take place after the respective course. EANM will not be held liable for cancellation fees of hotels\, airlines or other means of transportation.
URL:https://esmit.eanm.org/event/cardiac-amyloidosis-imaging-history-status-quo-and-outlook/
LOCATION:Future Health Lab\, Alfred-Adler-Straße 1\, Vienna\, 1100\, Austria
CATEGORIES:Clinical Nuclear Medicine,Onsite Course
END:VEVENT
END:VCALENDAR